{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:44:47Z","timestamp":1783687487049,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001391","name":"Whitehall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt, Jr. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00213-021-05967-9","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T01:02:42Z","timestamp":1630890162000},"page":"3499-3509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Granulocyte colony-stimulating factor (G-CSF) enhances cocaine effects in the nucleus accumbens via a dopamine release\u2013based mechanism"],"prefix":"10.1007","volume":"238","author":[{"given":"Lillian J.","family":"Brady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty R.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"Lucerne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew D.","family":"Kiraly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-0623","authenticated-orcid":false,"given":"Erin S.","family":"Calipari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"5967_CR35","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1126\/science.1067859","volume":"295","author":"EC Beattie","year":"2002","unstructured":"Beattie EC et al (2002) Control of synaptic strength by glial TNFalpha. Science 295:2282\u20132285","journal-title":"Science"},{"key":"5967_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41386-018-0125-6","volume":"44","author":"JB Becker","year":"2019","unstructured":"Becker JB, Chartoff E (2019) Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology 44:166\u2013183","journal-title":"Neuropsychopharmacology"},{"key":"5967_CR2","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/acschemneuro.9b00309","volume":"10","author":"LJ Brady","year":"2019","unstructured":"Brady LJ, Hofford RS, Tat J, Calipari ES, Kiraly DD (2019) Granulocyte-colony stimulating factor alters the pharmacodynamic properties of cocaine in female mice. ACS Chem Neurosci 10:4213\u20134220","journal-title":"ACS Chem Neurosci"},{"key":"5967_CR3","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1038\/ncomms13877","volume":"8","author":"ES Calipari","year":"2017","unstructured":"Calipari ES et al (2017) Dopaminergic dynamics underlying sex-specific cocaine reward. Nat Commun 8:13877","journal-title":"Nat Commun"},{"key":"5967_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-017-01881-x","volume":"9","author":"ES Calipari","year":"2018","unstructured":"Calipari ES et al (2018) Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine. Nat Commun 9:9","journal-title":"Nat Commun"},{"key":"5967_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04125.x","author":"X-Q Cao","year":"2006","unstructured":"Cao X-Q et al (2006) Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2\/Bax expression levels. J Neurochem. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04125.x","journal-title":"J Neurochem"},{"key":"5967_CR6","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1073\/pnas.0600905103","volume":"103","author":"R Chen","year":"2006","unstructured":"Chen R et al (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. PNAS 103:9333\u20139338","journal-title":"PNAS"},{"key":"5967_CR7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/exnr.2002.7911","volume":"176","author":"DJ Clarke","year":"2002","unstructured":"Clarke DJ, Branton RL (2002) A role for tumor necrosis factor \u03b1 in death of dopaminergic neurons following neural transplantation. Exp Neurol 176:154\u2013162","journal-title":"Exp Neurol"},{"key":"5967_CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R (2018) Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev 98:477\u2013504","journal-title":"Physiol Rev"},{"key":"5967_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/gbb.12645","volume":"19","author":"U Datta","year":"2020","unstructured":"Datta U et al (2020) Prospects for finding the mechanisms of sex differences in addiction with human and model organism genetic analysis. Genes Brain Behav 19:645","journal-title":"Genes Brain Behav"},{"key":"5967_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(99)00372-6","volume":"375","author":"G Di Chiara","year":"1999","unstructured":"Di Chiara G (1999) Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375:13\u201330","journal-title":"Eur J Pharmacol"},{"key":"5967_CR11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/7854_2016_13","volume":"31","author":"JC Felger","year":"2017","unstructured":"Felger JC (2017) The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications. Curr Top Behav Neurosci 31:199\u2013219","journal-title":"Curr Top Behav Neurosci"},{"key":"5967_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yfrne.2012.09.003","volume":"33","author":"JC Felger","year":"2012","unstructured":"Felger JC, Miller AH (2012) Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol 33:315\u2013327","journal-title":"Front Neuroendocrinol"},{"key":"5967_CR13","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC et al (2013) Chronic interferon-\u03b1 decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38:2179\u20132187","journal-title":"Neuropsychopharmacology"},{"key":"5967_CR14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/hup.1251","volume":"27","author":"HC Fox","year":"2012","unstructured":"Fox HC et al (2012) Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum Psychopharmacol 27:156\u2013166","journal-title":"Hum Psychopharmacol"},{"key":"5967_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.09.025","volume":"526","author":"IHA Franken","year":"2005","unstructured":"Franken IHA, Booij J, van den Brink W (2005) The role of dopamine in human addiction: From reward to motivated attention. Eur J Pharmacol 526:199\u2013206","journal-title":"Eur J Pharmacol"},{"key":"5967_CR16","doi-asserted-by":"crossref","first-page":"13629","DOI":"10.1038\/s41598-021-93075-1","volume":"11","author":"ST Galv\u00e1n","year":"2021","unstructured":"Galv\u00e1n ST et al (2021) Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder. Sci Rep 11:13629","journal-title":"Sci Rep"},{"key":"5967_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","volume":"18","author":"GE Hodes","year":"2015","unstructured":"Hodes GE, Kana V, Menard C, Merad M, Russo SJ (2015) Neuroimmune mechanisms of depression. Nat Neurosci 18:1386\u20131393","journal-title":"Nat Neurosci"},{"key":"5967_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ynstr.2016.03.003","volume":"4","author":"GE Hodes","year":"2016","unstructured":"Hodes GE, M\u00e9nard C, Russo SJ (2016) Integrating interleukin-6 into depression diagnosis and treatment. Neurobiology of Stress 4:15\u201322","journal-title":"Neurobiology of Stress"},{"key":"5967_CR19","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1111\/ejn.14143","volume":"50","author":"RS Hofford","year":"2019","unstructured":"Hofford RS, Russo SJ, Kiraly DD (2019) Neuroimmune mechanisms of psychostimulant and opioid use disorders. Eur J Neurosci 50:2562\u20132573","journal-title":"Eur J Neurosci"},{"key":"5967_CR20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1523\/JNEUROSCI.1452-20.2020","volume":"41","author":"RS Hofford","year":"2021","unstructured":"Hofford RS et al (2021) Granulocyte-colony stimulating factor reduces cocaine-seeking and downregulates glutamatergic synaptic proteins in medial prefrontal cortex. J Neurosci 41:1553\u20131565","journal-title":"J Neurosci"},{"key":"5967_CR21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neurobiolaging.2006.05.037","volume":"28","author":"H-Y Huang","year":"2007","unstructured":"Huang H-Y, Lin S-Z, Kuo J-S, Chen W-F, Wang M-J (2007) G-CSF protects dopaminergic neurons from 6-OHDA-induced toxicity via the ERK pathway. Neurobiol Aging 28:1258\u20131269","journal-title":"Neurobiol Aging"},{"key":"5967_CR22","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","volume":"18","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979\u20131986","journal-title":"J Neurosci"},{"key":"5967_CR23","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","volume":"95","author":"SR Jones","year":"1998","unstructured":"Jones SR et al (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95:4029\u20134034","journal-title":"Proc Natl Acad Sci USA"},{"key":"5967_CR24","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1074\/jbc.M115.707224","volume":"291","author":"AS Kumar","year":"2016","unstructured":"Kumar AS et al (2016) Molecular mechanism of regulation of MTA1 expression by granulocyte colony-stimulating factor. J Biol Chem 291:12310\u201312321","journal-title":"J Biol Chem"},{"key":"5967_CR25","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.1116-18.2018","volume":"38","author":"MG Kutlu","year":"2018","unstructured":"Kutlu MG et al (2018) Granulocyte colony stimulating factor enhances reward learning through potentiation of mesolimbic dopamine system function. J Neurosci 38:8845\u20138859","journal-title":"J Neurosci"},{"key":"5967_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/npp.2016.121","volume":"42","author":"MJ Lacagnina","year":"2017","unstructured":"Lacagnina MJ, Rivera PD, Bilbo SD (2017) Glial and neuroimmune mechanisms as critical modulators of drug use and abuse. Neuropsychopharmacology 42:156\u2013177","journal-title":"Neuropsychopharmacology"},{"key":"5967_CR27","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1523\/JNEUROSCI.3481-13.2014","volume":"34","author":"GM Lewitus","year":"2014","unstructured":"Lewitus GM, Pribiag H, Duseja R, St-Hilaire M, Stellwagen D (2014) An adaptive role of TNF\u03b1 in the regulation of striatal synapses. J Neurosci 34:6146\u20136155","journal-title":"J Neurosci"},{"key":"5967_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuron.2016.03.030","volume":"90","author":"GM Lewitus","year":"2016","unstructured":"Lewitus GM et al (2016) Microglial TNF-\u03b1 suppresses cocaine-induced plasticity and behavioral sensitization. Neuron 90:483\u2013491","journal-title":"Neuron"},{"key":"5967_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02358-w","volume":"4","author":"AJ L\u00f3pez","year":"2021","unstructured":"L\u00f3pez AJ et al (2021) Cocaine self-administration induces sex-dependent protein expression in the nucleus accumbens. Commun Biol 4:1\u201313","journal-title":"Commun Biol"},{"key":"5967_CR30","doi-asserted-by":"crossref","first-page":"108598","DOI":"10.1016\/j.neuropharm.2021.108598","volume":"192","author":"KE Lucerne","year":"2021","unstructured":"Lucerne KE, Osman A, Meckel KR, Kiraly DD (2021) Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 192:108598","journal-title":"Neuropharmacology"},{"key":"5967_CR31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/npp.2016.158","volume":"42","author":"A Meltzer","year":"2017","unstructured":"Meltzer A, Van de Water J (2017) The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 42:284\u2013298","journal-title":"Neuropsychopharmacology"},{"key":"5967_CR32","doi-asserted-by":"crossref","unstructured":"Mervosh NL, et al. (2018) Granulocyte-colony-stimulating factor alters the proteomic landscape of the ventral tegmental area. Proteomes 6","DOI":"10.3390\/proteomes6040035"},{"key":"5967_CR33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1471-4159.2006.03727.x","volume":"97","author":"K Meuer","year":"2006","unstructured":"Meuer K et al (2006) Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson\u2019s disease. J Neurochem 97:675\u2013686","journal-title":"J Neurochem"},{"key":"5967_CR34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller AH, Raison CL (2016) The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 16:22\u201334","journal-title":"Nat Rev Immunol"},{"key":"5967_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","volume":"30","author":"AH Miller","year":"2013","unstructured":"Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297\u2013306","journal-title":"Depress Anxiety"},{"key":"5967_CR37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jnc.15034","volume":"155","author":"SO Nolan","year":"2020","unstructured":"Nolan SO et al (2020) Direct dopamine terminal regulation by local striatal microcircuitry. J Neurochem 155:475\u2013493","journal-title":"J Neurochem"},{"key":"5967_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","volume":"16","author":"DJ Nutt","year":"2015","unstructured":"Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PRA (2015) The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci 16:305\u2013312","journal-title":"Nat Rev Neurosci"},{"key":"5967_CR39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuron.2015.10.017","volume":"88","author":"V Pascoli","year":"2015","unstructured":"Pascoli V, Terrier J, Hiver A, L\u00fcscher C (2015) Sufficiency of mesolimbic dopamine neuron stimulation for the progression to addiction. Neuron 88:1054\u20131066","journal-title":"Neuron"},{"key":"5967_CR40","doi-asserted-by":"crossref","unstructured":"Rothaug M, Becker-Pauly C, Rose-John S (2016) The role of interleukin-6 signaling in nervous tissue. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863, 1218\u20131227","DOI":"10.1016\/j.bbamcr.2016.03.018"},{"key":"5967_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-8993(96)01371-6","volume":"747","author":"H Shuto","year":"1997","unstructured":"Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R (1997) Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747:348\u2013351","journal-title":"Brain Res"},{"key":"5967_CR42","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/npp.2017.24","volume":"42","author":"CA Siciliano","year":"2017","unstructured":"Siciliano CA, Jones SR (2017) Cocaine potency at the dopamine transporter tracks discrete motivational states during cocaine self-administration. Neuropsychopharmacology 42:1893\u20131904","journal-title":"Neuropsychopharmacology"},{"key":"5967_CR43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nature04671","volume":"440","author":"D Stellwagen","year":"2006","unstructured":"Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440:1054\u20131059","journal-title":"Nature"},{"key":"5967_CR44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3727\/096368916X694247","volume":"26","author":"S-T Tsai","year":"2017","unstructured":"Tsai S-T et al (2017) Neuroprotection of granulocyte colony-stimulating factor for early stage Parkinson\u2019s disease. Cell Transplant 26:409\u2013416","journal-title":"Cell Transplant"},{"key":"5967_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2013.07.038","volume":"253","author":"F van Heesch","year":"2013","unstructured":"van Heesch F et al (2013) Systemic tumor necrosis factor-alpha decreases brain stimulation reward and increases metabolites of serotonin and dopamine in the nucleus accumbens of mice. Behav Brain Res 253:191\u2013195","journal-title":"Behav Brain Res"},{"key":"5967_CR46","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","volume":"26","author":"BJ Venton","year":"2006","unstructured":"Venton BJ et al (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206\u20133209","journal-title":"J Neurosci"},{"key":"5967_CR47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-0173(90)90015-G","volume":"15","author":"RM Wightman","year":"1990","unstructured":"Wightman RM, Zimmerman JB (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res Brain Res Rev 15:135\u2013144","journal-title":"Brain Res Brain Res Rev"},{"key":"5967_CR48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0306-4522(88)90255-2","volume":"25","author":"RM Wightman","year":"1988","unstructured":"Wightman RM et al (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25:513\u2013523","journal-title":"Neuroscience"},{"key":"5967_CR49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrn.2016.69","volume":"17","author":"ES Wohleb","year":"2016","unstructured":"Wohleb ES, Franklin T, Iwata M, Duman RS (2016) Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 17:497\u2013511","journal-title":"Nat Rev Neurosci"},{"key":"5967_CR50","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1523\/JNEUROSCI.21-16-06338.2001","volume":"21","author":"Q Wu","year":"2001","unstructured":"Wu Q, Reith ME, Kuhar MJ, Carroll FI, Garris PA (2001) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 21:6338\u20136347","journal-title":"J Neurosci"},{"key":"5967_CR51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jneumeth.2011.03.001","volume":"202","author":"JT Yorgason","year":"2011","unstructured":"Yorgason JT, Espa\u00f1a RA, Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202:158\u2013164","journal-title":"J Neurosci Methods"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-021-05967-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-021-05967-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T08:10:55Z","timestamp":1638173455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-021-05967-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5967"],"URL":"https:\/\/doi.org\/10.1007\/s00213-021-05967-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.19.452968","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"10 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}